EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Two-Track Model of Huntington’s Disease Pathology: Striatal Atrophy Mediates Maladaptive Immune Dysregulation

H Jeremy Bockholt iD, Jordan D Clemsen, Bradley T Baker, Vince D Calhoun, Jane S Paulsen iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27052384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von H Jeremy Bockholt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Atlanta, GA 30303, USA. Hauptthemen laut MEDLINE: Huntington Disease, Corpus Striatum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CHDI Foundation, NIH/NINDS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington’s disease (HD) is characterized by progressive striatal atrophy and complex proteomic changes in the central nervous system. Using the ultrasensitive Next-Gen Ultra-Sensitive Immunoassay (NULISA) proteomic platform, we analyzed cerebrospinal fluid (CSF) from 88 persons with HD to dissect the biological correlates of gray matter loss. Our findings reveal a distinct “Two-Track” model of pathology. The first track, marked by the axonal damage protein neurofilament light chain (NEFL), showed a strong inverse correlation with putamen volume (Pearson r = −0.53, p < 0.001), reinforcing its utility as a proxy for structural neurodegeneration. The second track was defined by a positive association between the immune regulator TNFRSF8 (CD30) and putamen volume (Pearson r = 0.36, p < 0.001), reflecting a decline in active immune-regulatory signaling as striatal atrophy advances. Given its established role in immune modulation, TNFRSF8 was pre-specified for follow-up to further interrogate this neuro-immune axis. Crucially, TNFRSF8 maintained an independent association with striatal volume (Beta = 0.24, p = 0.008) even after controlling for NEFL, genetic burden (CAG-Age Product score), and sex. Supplementary analyses confirmed that this structural–immune axis is localized specifically to the striatum—showing no association with generic structural control regions—and is driven by CAG repeat length rather than chronological aging. Furthermore, bidirectional mediation analysis supported an atrophy-driven model, where striatal volume statistically mediates the relationship between genetic burden and downstream immune dysregulation (p = 0.010). These results demonstrate that maladaptive immune signaling is a distinct pathological correlate in HD, separable from general cytoskeletal damage. This dual-axis framework warrants evaluation in larger longitudinal and interventional studies to guide future biomarker-driven patient stratification and target engagement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseCorpus StriatumHumansAtrophyFemaleMaleMiddle AgedBiomarkersNeurofilament ProteinsAdultProteomicsAgedPutamen

Stichwörter der Autor:innen

Huntington’s diseaseNULISAbiomarkersneuro-immune axisneurodegenerationneuroinflammationproteomicsstriatum

Substanzen

BiomarkersNeurofilament Proteinsneurofilament protein L

Autor:innen und Institutionen

  • Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Atlanta, GA 30303, USA.
  • School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
  • Department of Neurology, Emory University, Atlanta, GA 30322, USA.
  • Department of Neurology, University of Wisconsin-Madison, Madison, WI 53706, USA.

ORCID-Profile: H Jeremy Bockholt, Jane S Paulsen

Förderung

  • CHDI Foundation
  • NIH/NINDS
  • NINDS NIH HHS
  • NINDS/NIH
  • CHDI

Zitieren

APA

Bockholt, H. J., Clemsen, J. D., Baker, B. T., Calhoun, V. D., & Paulsen, J. S. (2026). A Two-Track Model of Huntington’s Disease Pathology: Striatal Atrophy Mediates Maladaptive Immune Dysregulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052384

Vancouver

Bockholt HJ, Clemsen JD, Baker BT, Calhoun VD, Paulsen JS. A Two-Track Model of Huntington’s Disease Pathology: Striatal Atrophy Mediates Maladaptive Immune Dysregulation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052384

BibTeX
@article{Bockholt2026,
  author = {Bockholt, H Jeremy and Clemsen, Jordan D and Baker, Bradley T and Calhoun, Vince D and Paulsen, Jane S},
  title = {A Two-Track Model of Huntington’s Disease Pathology: Striatal Atrophy Mediates Maladaptive Immune Dysregulation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27052384}
}
Kostenlos starten →